Cargando…
Analgesic effects of a novel pH-dependent μ-opioid receptor agonist in models of neuropathic and abdominal pain
Recently, (±)-N-(3-fluoro-1-phenethylpiperidine-4-yl)-N-phenyl propionamide (NFEPP), a newly designed μ-opioid receptor (MOR) agonist with a low pKa, has been shown to produce injury-restricted analgesia in models of inflammatory and postoperative pain, without exhibiting typical opioid side effects...
Autores principales: | Rodriguez-Gaztelumendi, Antonio, Spahn, Viola, Labuz, Dominika, Machelska, Halina, Stein, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203420/ https://www.ncbi.nlm.nih.gov/pubmed/29994988 http://dx.doi.org/10.1097/j.pain.0000000000001328 |
Ejemplares similares
-
Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist
por: Spahn, Viola, et al.
Publicado: (2018) -
Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons – Effects of Nerve Injury
por: Stötzner, Philip, et al.
Publicado: (2018) -
Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain
por: Labuz, Dominika, et al.
Publicado: (2016) -
pK(a) of opioid ligands as a discriminating factor for side effects
por: Del Vecchio, Giovanna, et al.
Publicado: (2019) -
Author Correction: pK(a) of opioid ligands as a discriminating factor for side effects
por: Del Vecchio, Giovanna, et al.
Publicado: (2020)